Showing results (1391-1400 of 2,426) with videos related to

Sort By:
Pageof 243
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|November 1, 1986
Influence of housing conditions for mice on the results of a dermal oncogenicity bioassayL R DePass, C S Weil, B Ballantyne, et al.
International Journal of Legal Medicine|November 5, 2022
Targeted S5 RNA sequencing assay for the identification and direct association of common body fluids with DNA donors in mixturesErin Hanson, Guro Dørum, Manuel Zamborlin, et al.
International Journal of Molecular Sciences|June 26, 2025
Effects of Sodium Alginate Infusion on Intramammary Immunity Against Subclinical Mastitis in Dairy CowsYu-I Pan, Yu-Chia Lin, Jai-Wei Lee, et al.
Bone & Joint Open|December 18, 2025
Impact of femoral component design on periprosthetic fracture risk in total hip arthroplasty : ten to 15-year follow-up of composite beam and polished taper slip componentsGareth S Turnbull, Bin Chen, Muhammad A Akhtar, et al.
Journal of Clinical Lipidology|June 9, 2026
Correlation between serum and plasma lipoprotein(a) measurements: ARIC studyYakubu Bene-Alhasan, Caroline Sun, Arsalan Hamid, et al.
Cureus|August 3, 2023
Steven-Johnson Syndrome Induced by Lamotrigine and Valproic Acid in a Pediatric Patient: A Case ReportEunice-Jazmín Espinosa-Aguilar, Steven-Andrés Piña-Ballantyne, Keren-Lizeth Espinosa-Aguilar, et al.
Cardiovascular Drugs and Therapy|March 19, 2011
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglyceridesChristie M Ballantyne, Peter H Jones, Maureen T Kelly, et al.
Lipids in Health and Disease|September 5, 2015
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease riskJeffrey B Rosen, Christie M Ballantyne, Willa A Hsueh, et al.
Atherosclerosis|April 27, 1999
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteinsH J Pownall, D Brauchi, C Kilinç, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 10, 2011
A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in miceNathan C Ni, Dong Yan, Laurel L Ballantyne, et al.
Pageof 243